Swiss Dream CBD

Swiss Dream represents a significant achievement in cannabinoid breeding, developed by Kannabia Seed Company through extensive cultivation research. This sativa-dominant cultivar delivers an impressive CBD-to-THC ratio of 26:1, featuring cannabidiol concentrations reaching 7% while maintaining THC levels at approximately 0.22% throughout the plant, consistently staying under 0.3% across virtually all cultivation environments.

Bred from two sativa genetics, Swiss Dream was engineered to minimize psychoactive compounds, making it an ideal selection for medical users seeking therapeutic benefits without intoxication. The experience produces mental clarity paired with profound physical relaxation, despite the absence of significant THC influence.

This strain demonstrates resilience in both indoor and outdoor growing conditions, offering reliability for novice cultivators pursuing therapeutic applications. The plant exhibits vigorous lateral branching with compressed spacing between nodes, suggesting the need for growth management—particularly when cultivating indoors.

Swiss Dream displays distinctive olive-toned foliage with dense, conical flower structures. The aroma profile combines floral and spice notes that contrast interestingly with the taste, which features prominent diesel undertones accented by subtle ginger nuances.